Ligand Pharmaceuticals Ownership | Who Owns Ligand Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Ligand Pharmaceuticals Ownership Summary


Ligand Pharmaceuticals is owned by 99.50% institutional investors, 2.31% insiders. Blackrock is the largest institutional shareholder, holding 16.19% of LGND shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.89% of its assets in Ligand Pharmaceuticals shares.

LGND Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLigand Pharmaceuticals99.50%2.31%-1.81%
SectorHealthcare Stocks 487.91%11.08%-398.99%
IndustryBiotech Stocks 307.10%11.11%-218.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock2.87M16.19%$241.95M
Blackrock funding, inc. /de2.91M15.13%$331.23M
Vanguard group2.09M11.32%$223.47M
Janus henderson group1.02M5.51%$108.76M
Macquarie group884.38K4.80%$94.76M
Dimensional fund advisors lp723.02K3.93%$77.47M
State street688.77K3.88%$58.04M
Congress asset management co /ma667.31K3.46%$118.21M
Stephens investment management group604.81K3.14%$68.76M
Chicago capital568.61K2.95%$100.72M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ashford capital management322.21K3.67%$27.15M
Villere st denis j287.12K3.14%$32.64M
Cardinal capital management llc /ct133.67K3.08%$11.26M
Rice hall james & associates294.49K2.84%$52.17M
Private capital management229.25K2.52%$26.06M
Chicago capital568.61K2.48%$100.72M
Acuitas investments27.51K2.42%$2.95M
Essex investment management65.25K1.26%$6.99M
Penn capital management company120.38K1.18%$13.70M
Stephens investment management group604.81K0.91%$68.76M

Top Buyers

HolderShares% AssetsChange
Ashford capital management322.21K3.67%125.67K
Vanguard group2.09M0.00%115.00K
Franklin resources185.40K0.01%90.74K
Private capital management229.25K2.52%81.13K
Massachusetts financial services co /ma/339.74K0.01%61.95K

Top Sellers

HolderShares% AssetsChange
Cardinal capital management llc /ct133.67K3.08%-425.56K
William blair investment management---205.69K
Knott david m jr---85.00K
Man group---68.66K
Castleark management---66.46K

New Positions

HolderShares% AssetsChangeValue
Norges bank46.29K0.00%46.29K$4.96M
Moody aldrich partners25.88K0.87%25.88K$4.59M
Capstone investment advisors15.37K0.00%15.37K$1.75M
Canada pension plan investment board4.00K0.00%4.00K$454.72K
Edgestream partners3.77K0.01%3.77K$428.00K

Sold Out

HolderChange
Mendota financial group-1.00
Cgc financial services-3.00
Tidemark-4.00
Stephens consulting-5.00
Voisard asset management group-5.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20252662.31%19,162,9152.69%991.05%14410.77%82-5.75%
Mar 31, 2025258-1.53%18,645,9442.31%970.99%128-15.23%8846.67%
Dec 31, 2024239-2.85%16,852,409-6.71%910.95%135-577.55%
Sep 30, 20242454.26%18,062,9964.71%981.04%1359.76%53-26.39%
Jun 30, 20242322.65%17,221,3794.99%971.08%12223.23%70-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.15M5.89%-
Delaware Small Cap Core I655.86K3.59%-57.44K
Macquarie Small Cap Core I670.37K3.44%-14.18K
Janus Henderson US SMID Cap Growth MA596.82K3.09%596.78K
Janus Henderson US SMID Cap Growth596.82K3.09%-7.04K
Janus Henderson Triton D596.82K3.07%-7.04K
Vanguard Total Stock Mkt Idx Inv574.56K2.96%-12.07K
Vanguard US Total Market Shares ETF529.85K2.75%-
iShares Russell 2000 ETF461.37K2.37%-
Vanguard Small Cap Index444.90K2.29%-2.72K

Recent Insider Transactions


DateNameRoleActivityValue
Oct 01, 2025KOZARICH JOHN W-Sell$16.67K
Oct 01, 2025KOZARICH JOHN W-Sell$4.26K
Oct 01, 2025KOZARICH JOHN W-Sell$34.97K
Oct 01, 2025KOZARICH JOHN W-Sell$27.90K
Sep 23, 2025Aryeh Jason-Sell$791.22K

Insider Transactions Trends


DateBuySell
2025 Q4-4
2025 Q3-8
2025 Q253
2025 Q1-1
2024 Q4-2

LGND Ownership FAQ


Who Owns Ligand Pharmaceuticals?

Ligand Pharmaceuticals shareholders are primarily institutional investors at 99.50%, followed by 2.31% insiders and -1.81% retail investors. The average institutional ownership in Ligand Pharmaceuticals's industry, Biotech Stocks , is 307.10%, which Ligand Pharmaceuticals falls below.

Who owns the most shares of Ligand Pharmaceuticals?

Ligand Pharmaceuticals’s largest shareholders are Blackrock (2.87M shares, 16.19%), Blackrock funding, inc. /de (2.91M shares, 15.13%), and Vanguard group (2.09M shares, 11.32%). Together, they hold 42.65% of Ligand Pharmaceuticals’s total shares outstanding.

Does Blackrock own Ligand Pharmaceuticals?

Yes, BlackRock owns 16.19% of Ligand Pharmaceuticals, totaling 2.87M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 241.95M$. In the last quarter, BlackRock increased its holdings by 3.23K shares, a 0.11% change.

Who is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ashford capital management is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 3.67% of its assets in 322.21K Ligand Pharmaceuticals shares, valued at 27.15M$.

Who is the top mutual fund holder of Ligand Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Ligand Pharmaceuticals shares, with 5.89% of its total shares outstanding invested in 1.15M Ligand Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools